A laboratory study out of Roswell Park Comprehensive Cancer Center outlines a new way to boost the effectiveness of chimeric ...

Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...

Biotech investors hunting for explosive growth may want to look closely at two emerging innovators making significant ...

The Malinauskas Labor Government will establish a dedicated CAR T-cell therapy service in South Australia, in a major advancement in the treatment of ...

On December 4, 2025, the FDA approved a new indication for Bristol Myer Squibb’s BREYANZI (lisocabtagene maraleucel) for the treatment of adults ...

A rigorous medical journey ends in a breakthrough, in the form of CAR-T therapy, achieving a rare, hard-won cancer-free result.

Glioblastoma is the most common form of brain cancer in adults, and its consequences are usually quick and fatal. After ...

Baystreet.ca News Commentary – Artificial intelligence and platform-based approaches reshaped cancer treatment development in ...

An experimental vaccine targeting aggressive triple-negative breast cancer (TNBC) has shown encouraging early results in ...

Incidence of venous thromboembolism remains 'substantial' despite expert guidelines and newer risk prediction scores ...

Dec 12 (Reuters) - Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, ...

Jason Collins, who said he could die within weeks, praised Singapore as 'the city of the future', where he got approval ...